James E. Dentzer

This profile gathers the share dealings of James E. Dentzer across 2 companies, led by Imunon, Inc. and Curis Inc. Over a trading history stretching from 27 January 2022 to 31 July 2026, the count stands at 5 filings.

Sales make up the whole of the open-market record (1 sale, €6,805). Besides market trades, the filings include 3 share grants.

On 4 August 2026 came the latest disclosure, a share grant for €9,572 in Imunon, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.